Never buy a biotech till there is blood in the street

Does anyone truly understand clinical trials, related abstracts and what the NPV of a drug in a phase one (for that matter two or three) trial will be? The answer is no and the new game in town is for ALGOS (aka a**holes) to take some very obscure press release from a Biotech (look at $INCY last week) and try to short it to zero. first of all before you panic and sell (or buy) find out what they said first, make a decision based on some bit of rational thinking and 1) run screaming for the exit or 2) back up the truck. as an important aside here , never fall in love with anything.